Issue Information.
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 4, p. i, doi. 10.1111/ejn.14024
- Publication type:
- Article
Works matching IS 0953816X AND DT 2019 AND VI 49 AND IP 4
Results: 14
1
2
Issue Information.
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 4, p. i, doi. 10.1111/ejn.14024
- Publication type:
- Article
3
Induced pluripotent stem cell‐based modeling of mutant LRRK2‐associated Parkinson's disease.
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 4, p. 561, doi. 10.1111/ejn.14345
- By:
- Publication type:
- Article
4
Are PARKIN patients ideal candidates for dopaminergic cell replacement therapies?
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 4, p. 453, doi. 10.1111/ejn.14314
- By:
- Publication type:
- Article
5
Genetically engineered animal models of Parkinson's disease: From worm to rodent.
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 4, p. 533, doi. 10.1111/ejn.14300
- By:
- Publication type:
- Article
6
Engineering synucleinopathy‐resistant human dopaminergic neurons by CRISPR‐mediated deletion of the SNCA gene.
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 4, p. 510, doi. 10.1111/ejn.14286
- By:
- Publication type:
- Article
7
Nonhypoxic pharmacological stabilization of Hypoxia Inducible Factor 1α: Effects on dopaminergic differentiation of human neural stem cells.
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 4, p. 497, doi. 10.1111/ejn.14284
- By:
- Publication type:
- Article
8
Mitochondrial dysfunction and oxidative stress in induced pluripotent stem cell models of Parkinson's disease.
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 4, p. 525, doi. 10.1111/ejn.14264
- By:
- Publication type:
- Article
9
Mitral cells and the glucagon‐like peptide 1 receptor: The sweet smell of success?
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 4, p. 422, doi. 10.1111/ejn.14115
- By:
- Publication type:
- Article
10
Cell‐based therapy for Parkinson's disease: A journey through decades toward the light side of the Force.
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 4, p. 463, doi. 10.1111/ejn.14109
- By:
- Publication type:
- Article
11
Trophic factors for Parkinson's disease: Where are we and where do we go from here?
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 4, p. 440, doi. 10.1111/ejn.14102
- By:
- Publication type:
- Article
12
Encapsulation of young donor age dopaminergic grafts in a GDNF‐loaded collagen hydrogel further increases their survival, reinnervation, and functional efficacy after intrastriatal transplantation in hemi‐Parkinsonian rats.
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 4, p. 487, doi. 10.1111/ejn.14090
- By:
- Publication type:
- Article
13
Primary tissue for cellular brain repair in Parkinson's disease: Promise, problems and the potential of biomaterials.
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 4, p. 472, doi. 10.1111/ejn.14051
- By:
- Publication type:
- Article
14
Issue Information.
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 4, p. i, doi. 10.1111/ejn.14024
- Publication type:
- Article